Current Cancer Drug Targets


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 18 Issue: 6, July 2018

Meet Our Editorial Board Member free to download

Volume:18   Issue: 6
Pp: 513-513
Franco Patrone
DOI: 10.2174/156800961806180611103149
Published on: 10 June, 2018

Tunneling Nanotubes: A Versatile Target for Cancer Therapy

Volume:18   Issue: 6
Pp: 514-521
Pragyaparamita Sahu, Soumya Ranjan Jena and Luna Samanta*
DOI: 10.2174/1568009618666171129222637
Published on: 29 November, 2017

Towards Prevention of Ovarian Cancer

Volume:18   Issue: 6
Pp: 522-537
Aus Tariq Ali*
DOI: 10.2174/1568009618666180102103008
Published on: 01 January, 2018

Oxidative Stress and Cancer: The Role of Nrf2

Volume:18   Issue: 6
Pp: 538-557
Soraya Sajadimajd and Mozafar Khazaei*
DOI: 10.2174/1568009617666171002144228
Published on: 02 October, 2017

Role of Glioma-associated GLI1 Oncogene in Carcinogenesis and Cancertargeted Therapy

Volume:18   Issue: 6
Pp: 558-566
Jie Wu, Dingxin Di, Chen Zhao, Yingyi Liu, Hongxia Chen, Yan Gong, Xianda Zhao and Honglei Chen*
DOI: 10.2174/1568009618666171129223533
Published on: 29 November, 2017

Fertility Drugs and Ovarian Cancer

Volume:18   Issue: 6
Pp: 567-576
Aus Tariq Ali*
DOI: 10.2174/1568009617666170620102049
Published on: 19 June, 2017

Oncolytic Tanapoxvirus Expressing Interleukin-2 is Capable of Inducing the Regression of Human Melanoma Tumors in the Absence of T Cells

Volume:18   Issue: 6
Pp: 577-591
Tiantian Zhang, Dennis H. Kordish, Yogesh R. Suryawanshi, Rob R. Eversole, Steven Kohler, Charles D. Mackenzie and Karim Essani*
DOI: 10.2174/1568009617666170630143931
Published on: 30 June, 2017

Diallyl Disulfide Inhibits Breast Cancer Stem Cell Progression and Glucose Metabolism by Targeting CD44/PKM2/AMPK Signaling

Volume:18   Issue: 6
Pp: 592-599
Xinhua Xie, Xiaojia Huang, Hailin Tang, Feng Ye, Lu Yang, Xiaofang Guo, Zhi Tian, Xiaofang Xie, Cheng Peng* and Xiaoming Xie*
DOI: 10.2174/1568009617666171024165657
Published on: 24 October, 2017

CX-4945, a Selective Inhibitor of Casein Kinase 2, Synergizes with B Cell Receptor Signaling Inhibitors in Inducing Diffuse Large B Cell Lymphoma Cell Death

Volume:18   Issue: 6
Pp: 608-616
Elisa Mandato, Sara Canovas Nunes, Fortunato Zaffino, Alessandro Casellato, Paolo Macaccaro, Laura Quotti Tubi, Andrea Visentin, Livio Trentin, Gianpietro Semenzato and Francesco Piazza*
DOI: 10.2174/1568009617666170427110450
Published on: 27 April, 2017